Are long-term care jobs harmful? Evidence from Germany.
- Published in:
- European Journal of Health Economics, 2021, v. 22, n. 5, p. 749, doi. 10.1007/s10198-021-01288-y
- By:
- Publication type:
- Article
Works matching IS 16187598 AND DT 2021 AND VI 22 AND IP 5
Results: 14
1
2
Bayesian modeling of health state preferences: could borrowing strength from existing countries' valuations produce better estimates.
- Published in:
- European Journal of Health Economics, 2021, v. 22, n. 5, p. 773, doi. 10.1007/s10198-021-01289-x
- By:
- Publication type:
- Article
3
Mapping PedsQL™ Generic Core Scales to EQ-5D-3L utility scores in transfusion-dependent thalassemia patients.
- Published in:
- European Journal of Health Economics, 2021, v. 22, n. 5, p. 735, doi. 10.1007/s10198-021-01287-z
- By:
- Publication type:
- Article
4
Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists.
- Published in:
- European Journal of Health Economics, 2021, v. 22, n. 5, p. 723, doi. 10.1007/s10198-021-01286-0
- By:
- Publication type:
- Article
5
Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analyses.
- Published in:
- European Journal of Health Economics, 2021, v. 22, n. 5, p. 711, doi. 10.1007/s10198-021-01285-1
- By:
- Publication type:
- Article
6
Correction to: How relevant are social costs in economic evaluations? The case of Alzheimer's disease.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
7
Correction to: A general framework for classifying costing methods for economic evaluation of health care.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
8
The impact of nurse staffing levels on nursing-sensitive patient outcomes: a multilevel regression approach.
- Published in:
- European Journal of Health Economics, 2021, v. 22, n. 5, p. 833, doi. 10.1007/s10198-021-01292-2
- By:
- Publication type:
- Article
9
Risky business, healthy lives: how risk perception, risk preferences and information influence consumer's risky health choices.
- Published in:
- European Journal of Health Economics, 2021, v. 22, n. 5, p. 811, doi. 10.1007/s10198-021-01291-3
- By:
- Publication type:
- Article
10
Has the development of cancer biomarkers to guide treatment improved health outcomes?
- Published in:
- European Journal of Health Economics, 2021, v. 22, n. 5, p. 789, doi. 10.1007/s10198-021-01290-4
- By:
- Publication type:
- Article
11
How Managed Entry Agreements can improve allocation in the public health system: a mechanism design approach.
- Published in:
- European Journal of Health Economics, 2021, v. 22, n. 5, p. 699, doi. 10.1007/s10198-021-01284-2
- By:
- Publication type:
- Article
12
A cost-effectiveness analysis of pembrolizumab with or without chemotherapy for the treatment of patients with metastatic, non-squamous non-small cell lung cancer and high PD-L1 expression in Switzerland.
- Published in:
- European Journal of Health Economics, 2021, v. 22, n. 5, p. 669, doi. 10.1007/s10198-021-01282-4
- By:
- Publication type:
- Article
13
Trust me; I know what I am doing investigating the effect of choice list elicitation and domain-relevant training on preference reversals in decision making for others.
- Published in:
- European Journal of Health Economics, 2021, v. 22, n. 5, p. 679, doi. 10.1007/s10198-021-01283-3
- By:
- Publication type:
- Article
14
The "red herring" after 20 years: ageing and health care expenditures.
- Published in:
- 2021
- By:
- Publication type:
- Editorial